Skip to content
Invitrocue - Transforming bioanalytics
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)
  • Home
  • About Us
    • Meet Invitrocue
    • Our Team
    • Partners
    • Corporate Governance
    • Careers
  • Oncology
    • Onco-PDO™
    • Patient FAQ
    • Physician FAQ
  • Preclinical Services
    • Overview
    • Drug Metabolism and Pharmacokinetics
    • Toxicology and Safety Assessment
    • Hepatocytes
    • 3D Cell Culture
    • Patient-derived Organoid (PDO)
    • Immunomodulatory Assays
    • Customized Assays and Disease Modelling
    • Invivocue – Humanized Mice
  • Shareholders
    • Reports
      • Financial Reports
      • Analyst Reports
    • Announcements
    • Contact Management
  • News & Resources
    • Publications
    • Conferences & Events
    • Press Releases
    • Privacy Policy
  • Contact Us
  • English
    • English
    • Deutsch
    • Español
    • Português
    • 中文 (中国)
    • 中文 (香港)

ASX Announcements

Change of Director's Interest Notice – Steven Fang

February 20, 2018

Change of Director’s Interest Notice – Steven Fang

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Change of Director's Interest Notice

February 14, 2018

Change of Director’s Interest Notice

Categories ASX Announcements, News

Initial Director's Interest Notice

February 12, 2018

Initial Director’s Interest Notice

Categories ASX Announcements

Appendix 3B

February 9, 2018

Appendix 3B

Categories ASX Announcements

Appointment of non-executive director

February 7, 2018

Appointment of non-executive director

Categories ASX Announcements

Appendix 4C & quarterly business update

January 31, 2018

Appendix 4C & quarterly business update

Categories ASX Announcements, Financial Reports
Post navigation
Older posts
Newer posts
← Previous Page1 … Page8 Page9 Page10 … Page16 Next →

Recent Posts

  • Elephas Announces Commercial Partnership with Invitrocue to Expand Personalized Oncology in Southeast Asia
  • Xylonix and Invitrocue form strategic clinical alliance to validate new method for combating IL-6 pathologies
  • Invitrocue and Angsana partner with Averywell to advance early lung cancer detection across Asia
  • Invitrocue announces merger with Angsana Molecular & Diagnostics Laboratory and Pathnova Laboratories
  • Strategic partnership & Financial advisor appointment

GET IN TOUCH

51 Science Park Road, #01-11/13 The Aries, Singapore Science Park II Singapore 117586

GENERAL / PHARMACOLOGY ENQUIRIES:

+65 6460 0497
contact@invitrocue.com

ONCO-PDO ENQUIRIES:

+65 6819 0181
onco-pdo@invitrocue.com

SERVICES

Home
About Us
Oncology
Preclinical Services
Investors
News & Resources
Contact Us

Logo Invitrocue
Icon-twitter-x Facebook-f Linkedin-in Youtube

© Copyright 2026 Invitrocue. All rights reserved
Impressum | Privacy Policy | Cookies Policy | Cookie Settings